Cargando…
Smad3 Mediates Diabetic Dyslipidemia and Fatty Liver in db/db Mice by Targeting PPARδ
Transforming growth factor-β (TGF-β)/Smad3 signaling has been shown to play important roles in fibrotic and inflammatory diseases. However, the role of Smad3 in dyslipidemia and non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes remains unclear, and whether targeting Smad3 has a therapeuti...
Autores principales: | He, Huijun, Zhong, Yu, Wang, Honglian, Tang, Patrick Ming-Kuen, Xue, Vivian Weiwen, Chen, Xiaocui, Chen, Jiaoyi, Huang, Xiaoru, Wang, Cheng, Lan, Huiyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380492/ https://www.ncbi.nlm.nih.gov/pubmed/37511155 http://dx.doi.org/10.3390/ijms241411396 |
Ejemplares similares
-
Smad3 deficiency promotes beta cell proliferation and function in db/db mice via restoring Pax6 expression
por: Sheng, Jingyi, et al.
Publicado: (2021) -
Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice
por: Liu, Peng, et al.
Publicado: (2018) -
Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice
por: Dong, Li, et al.
Publicado: (2021) -
AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice
por: Chung, Jeff Yat-Fai, et al.
Publicado: (2022) -
Huangqi decoction ameliorates kidney injury in db/db mice by regulating the BMP/Smad signaling pathway
por: Chen, Ying, et al.
Publicado: (2023)